Harmane produces hypotension following microinjection into the RVLM: Possible role of I1-imidazoline receptors

British Journal of Pharmacology

Volumn 129, Issue 6, 2000, Pages 1057-1059

  Musgrave, I F ^a   Badoer, E ^b  

^a RMIT UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Blood pressure; Clonidine; Harmane; Imidazoline receptors; RVLM; carbolines

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CARBOLINE DERIVATIVE; CLONIDINE; EFAROXAN; HARMAN; IMIDAZOLINE I1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; HYPOTENSION; MALE; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034104371     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703142     Document Type: Article

References (17)

1. BADOER, E. & MEROLLI, J. (1998). Neurons in the hypothalamic paraventricular nucleus that project to the rostral ventrolateral medulla are activated by haemorrhage. Brain Res., 791, 317-320.
2. 1-imidazoline receptors: an update. J. Hypertens., 16, (Suppl): S1-5
3. BOUSQUET, P. FELDMAN, J. & SCHWARTZ, J. (1984). Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther., 230, 232-236.
4. EGLEN, R.M., HUDSON, A.L., KENDALL, D.A., NUTT, D.J., MORGAN, N.G., WILSON, V.G. & DILLON, M. (1998). Seeing through a glass darkly - casting light on imidazoline I sites. Trends Pharmacol. Sci., 19, 381-390.
5. 1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J. Hypertens., 15, (Suppl): S9-23.
6. ERNSBERGER, P., GIULIANO, R., WILLETTE, R.N. & REIS, D.J. (1990). Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol Exp. Ther., 253, 408-418.
7. GRIGG, M., MUSGRAVE, I.F. & BARROW, C.J. (1998). Isolation and partial structure determination of a clonidine-displacing substance from bovine lung and brain. J. Autonom. Nerv. Sys., 72, 86-93.
8. 1-imidazoline receptors in the rostral ventrolateral medulla. J. Cardiovasc. Pharmacol., 24 (Suppl 1): SI -S8.
9. HEAD, G.A., BURKE, S.L. & CHAN, C.K. (1997a). Central imidazoline receptors and centrally acting anti-hypertensive agents. Clin. Exp. Hypertens., 19, 591-605.
10. HEAD, G.A., CHAN, C.K. & GODWIN, S.J. (1997b). Central cardiovascular actions of agmatine, a putative clonidine-displacing substance, in conscious rabbits. Neurochem. Int., 30, 37-45.
11. HEAD, G.A. & BURKE, S.L. (1998). Relative importance of medullary-brain nuclei for the sympatho-inhibitory actions of rilmenidine in the anaesthetized rabbit. J. Hypertens., 16, 503-517.
12. HUDSON, A.L., PRICE, R., TYACKE, R.J., LALIES, M.D., PARKER, C.A. & NUTT, D.J. (1999). Harmane, norharmane and tetrahydro β-carboline have high affinity for rat imidazoline binding sites. Br. J. Pharmacol., 126, 2P.
13. LI, G., REGUNATHAN, S., BARROW, C.J., ESHRAGHI, J., COOPER, R. & REIS, D.J. (1994). Agmatine: an endogenous clonidinedisplacing substance in the brain. Science, 263, 966-969.
14. MONCRIEFF, J. (1989). Determination of pharmacological levels of harmane, harmine and harmaline in mammalian brain tissue, cerebrospinal fluid and plasma by high-performance liquid chromatography with fluorimetric detection. J. Chromatogr., 496, 269-278.
15. 1-imidazoline receptors using microphysiometry and molecular modelling. J. Auton. Nerv. Syst., 72, 137-146.
16. REGUNATHAN, S. & REIS, D.J. (1996). Imidazoline receptors and their endogenous ligands. Ann. Rev. Pharmacol. Toxicol., 36, 511-544.
17. ROMMELSPACHER, H., MAY, T. & SUSILO, R. (1991). Betacarbolines and tetrahydroisoquinolines: detection and function in mammals. Planta Med., 57, S85-S92.